Microscopic Polyangiitis

Rheumatic Disease Clinics of North America

Volumn 36, Issue 3, 2010, Pages 545-558

  Chung, Sharon A ^a   Seo, Philip ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antineutrophil cytoplasmic autoantibodies; Microscopic polyangiitis; Pulmonary renal syndrome; Vasculitis

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOGLOBULIN G; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RITUXIMAB;

ABDOMINAL PAIN; ANCA ASSOCIATED VASCULITIS; BRONCHOSCOPY; CLINICAL TRIAL; DISEASE COURSE; DRUG DOSE TITRATION; FEVER; GASTROINTESTINAL DISEASE; GLOMERULONEPHRITIS; HEMATOLOGIC MALIGNANCY; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOFLUORESCENCE; INCIDENCE; INFERTILITY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; LABORATORY TEST; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; MICROSCOPIC POLYANGIITIS; MYALGIA; NEUROLOGIC DISEASE; NEUROPATHY; NONHUMAN; ONSET AGE; PATHOGENESIS; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REMISSION; REVIEW; SEX DIFFERENCE; SKIN DISEASE; SYMPTOMATOLOGY;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIMETABOLITES; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICROSCOPIC POLYANGIITIS; REMISSION INDUCTION;

EID: 77955249431     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.04.003     Document Type: Review

References (83)

1. Matteson E. Commemorative translation of the 130-year anniversary of the original article by Adolf Kussmaul and Rudolf Maier 1996, Mayo Foundation, Rochester (NY), Anonymous.
2. Matteson E.L. Historical perspective on the classification of vasculitis. Arthritis Care Res 2000, 13(2):122-127.
3. Wohlwill F. Über die nur mikroskopisch erkennbare Form der Periarteritis nodosa. Virchows Arch Pathol Anat Physiol 1923, 246:377-411. [in German].
4. Zeek P.M. Periarteritis nodosa and other forms of necrotizing angiitis. N Engl J Med 1953, 248(18):764-772.
5. Wainwright J., Davson J. The renal appearances in the microscopic form of periarteritis nodosa. J Pathol Bacteriol 1950, 62(2):189-196.
6. Savage C.O., Winearls C.G., Evans D.J., et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985, 56(220):467-483.
7. Jennette J., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
8. Kussmaul A., Maier R. Ueber eine bisher nicht beschriebenen Eigenthumliche arterienerkrankung (periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner muskellahmung Einhergeht. Dtsch Arch Klin Med 1866, 1:484-518. [in German].
9. Watts R., Lane S., Hanslik T., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007, 66(2):222-227.
10. Watts R.A., Jolliffe V.A., Carruthers D.M., et al. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 1996, 39(7):1208-1212.
11. Godman G., Churg J. Wegener's granulomatosis: pathology and review of the literature. Arch Pathol Lab Med 1954, 58:533-553.
12. Davies D., Moran J., Niall J., et al. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology. BMJ 1982, 285:606.
13. Falk R., Jennette J. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318:1651.
14. Guillevin L., Durand-Gasselin B., Cevallos R., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999, 42(3):421-430.
15. Lane S.E., Scott D.G., Heaton A., et al. Primary renal vasculitis in Norfolk-increasing incidence or increasing recognition?. Nephrol Dial Transplant 2000, 15(1):23-27.
16. Mohammad A.J., Jacobsson L.T., Mahr A.D., et al. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 2007, 46(8):1329-1337.
17. Koldingsnes W., Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000, 43(11):2481-2487.
18. Gonzalez-Gay M.A., Garcia-Porrua C., Guerrero J., et al. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003, 49(3):388-393.
19. Mahr A., Guillevin L., Poissonnet M., et al. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51(1):92-99.
20. Kallenberg C.G., Heeringa P., Stegeman C.A. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. Nature clinical practice. Rheumatology 2006, 2(12):661-670.
21. Guilpain P., Servettaz A., Goulvestre C., et al. Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis. Arthritis Rheum 2007, 56(7):2455-2463.
22. Mulder A., Heeringa P., Brouwer E., et al. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a FcgRII-dependent process. Clin Exp Immunol 1994, 98:270.
23. Little M.A., Smyth C.L., Yadav R., et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005, 106(6):2050-2058.
24. Xiao H., Heeringa P., Hu P., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110(7):955-963.
25. Schlieben D.J., Korbet S.M., Kimura R.E., et al. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 2005, 45(4):758-761.
26. Silva F., Specks U., Sethi S., et al. Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis. Am J Kidney Dis 2009, 54(3):542-545.
27. Falk R.J., Hoffman G.S. Controversies in small vessel vasculitis-comparing the rheumatology and nephrology views. Curr Opin Rheumatol 2007, 19(1):1-9.
28. Kain R., Exner M., Brandes R., et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008, 14(10):1088-1096.
29. Agard C., Mouthon L., Mahr A., et al. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?. Arthritis Rheum 2003, 49(5):709-715.
30. Lhote F., Cohen P., Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998, 7(4):238-258.
31. Jennette J.C., Thomas D.B., Falk R.J. Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 2001, 18(1):3-13.
32. Westman K.W., Bygren P.G., Olsson H., et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998, 9(5):842-852.
33. Levy J.B., Hammad T., Coulthart A., et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004, 66(4):1535-1540.
34. Lindic J., Vizjak A., Ferluga D., et al. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Ther Apher Dial 2009, 13(4):278-281.
35. Hellmark T., Niles J.L., Collins A.B., et al. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997, 8(3):376-385.
36. Lionaki S., Jennette J.C., Falk R.J. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol 2007, 29(4):459-474.
37. Lauque D., Cadranel J., Lazor R., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies " Orphelines" Pulmonaires (GERM" O" P). Medicine (Baltimore) 2000, 79(4):222-233.
38. Gomez-Puerta J.A., Espinosa G., Morla R., et al. Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil. Clin Exp Rheumatol 2009, 27(1):166-167.
39. Collins C.E., Quismorio F.P. Pulmonary involvement in microscopic polyangiitis. Curr Opin Pulm Med 2005, 11(5):447-451.
40. Franks T.J., Koss M.N. Pulmonary capillaritis. Curr Opin Pulm Med 2000, 6(5):430-435.
41. Schwarz M.I., Brown K.K. Small vessel vasculitis of the lung. Thorax 2000, 55(6):502-510.
42. Niles J.L., Bottinger E.P., Saurina G.R., et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996, 156(4):440-445.
43. Eschun G.M., Mink S.N., Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 2003, 123(1):297-301.
44. Birnbaum J., Danoff S., Askin F.B., et al. Microscopic polyangiitis presenting as a " pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?. Arthritis Rheum 2007, 56(6):2065-2071.
45. Tzelepis G.E., Kokosi M., Tzioufas A., et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010, 36(1):116-121.
46. Foulon G., Delaval P., Valeyre D., et al. ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med 2008, 102(10):1392-1398.
47. Ortiz-Santamaria V., Olive A., Holgado S., et al. Pulmonary aneurysms in microscopic polyangiitis. Clin Rheumatol 2003, 22(6):498-499.
48. Park J., Pagnoux C., Guillevin L., et al. Microscopic polyangiitis associated with diffuse panbronchiolitis. Intern Med 2004, 43(4):331-335.
49. Kluger N., et al. Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis. Br J Dermatol 2008, 159(3):615-620.
50. Kawakami T., Soma Y., Saito C., et al. Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview. Acta Derm Venereol 2006, 86(2):144-147.
51. Seishima M., Oyama Z., Oda M. Skin eruptions associated with microscopic polyangiitis. Eur J Dermatol 2004, 14(4):255-258.
52. Pagnoux C., Mahr A., Cohen P., et al. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005, 84(2):115-128.
53. Guillevin L., Pagnoux C., Teixeira L. Microscopic polyangiitis, in vasculitis 2008, 355-364. Oxford University Press, Oxford (UK). G. Ball, S. Bridges (Eds.).
54. Ueda S., Matsumoto M., Ahn T., et al. Microscopic polyangiitis complicated with massive intestinal bleeding. J Gastroenterol 2001, 36(4):264-270.
55. Spahn T.W., Ullerich H.J., Lebitz P., et al. Gastrointestinal bleeding secondary to hepatic artery involvement of microscopic polyangiitis: case report and review of the literature. Dig Dis Sci 2007, 52(6):1558-1561.
56. Tsai C.N., Chang C.M., Chuang C.H., et al. Extended colonic ulcerations in a patient with microscopic polyangiitis. Ann Rheum Dis 2004, 63(11):1521-1522.
57. Passam F.H., et al. Intestinal ischemia as the first manifestation of vasculitis. Semin Arthritis Rheum 2004, 34(1):431-441.
58. Ohnuma K., Hosono O., Katayose T., et al. Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin. Rheumatol Int 2009, [Epub ahead of print].
59. Takebayashi K., Aso Y., Kitamura H., et al. Microscopic polyangiitis presenting with liver dysfunction preceding rapidly progressive necrotizing glomerulonephritis. South Med J 2004, 97(9):911-914.
60. Nakamoto T., Yoshikawa M., Nakatani T., et al. Microscopic polyangiitis that presented liver dysfunction prior to noted renal manifestations. Intern Med 2000, 39(6):517-521.
61. Goritsas C.P., Repanti M., Papadaki E., et al. Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa. J Hepatol 1997, 26(3):727-730.
62. Iannone F., Falappone P., Pannarale G., et al. Microscopic polyangiitis associated with primary biliary cirrhosis. J Rheumatol 2003, 30(12):2710-2712.
63. Amezcua-Guerra L.M., Prieto P. Microscopic polyangiitis associated with primary biliary cirrhosis: a causal or casual association?. J Rheumatol 2006, 33(11):2351-2353.
64. Zhang W., Zhou G., Shi Q., et al. Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 2009, 27(1 Suppl 52):S65-S69.
65. Hattori N., Mori K., Misu K., et al. Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis. J Rheumatol 2002, 29(7):1408-1414.
66. Cattaneo L., Chierici E., Pavone L., et al. Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatr 2007, 78(10):1119-1123.
67. Furukawa Y., Matsumoto Y., Yamada M. Hypertrophic pachymeningitis as an initial and cardinal manifestation of microscopic polyangiitis. Neurology 2004, 63(9):1722-1724.
68. Ku B.D., Shin H.Y. Multiple bilateral non-hemorrhagic cerebral infarctions associated with microscopic polyangiitis. Clin Neurol Neurosurg 2009, 111(10):904-906.
69. Stone J., Talor M., Stebbing J., et al. Test characteristics of Immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 2000, 13(6):424-434.
70. Choi H.K., Merkel P.A., Walker A.M., et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000, 43(2):405-413.
71. Zhao M.H., Jayne D.R., Ardiles L.G., et al. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. Q J Med 1996, 89(4):259-265.
72. Bauer A., Jabs W.J., Sufke S., et al. Vasculitic purpura with antineutrophil cytoplasmic antibody-positive acute renal failure in a patient with Streptococcus bovis case and Neisseria subflava bacteremia and subacute endocarditis. Clin Nephrol 2004, 62(2):144-148.
73. Hermann J., Demel U., Stunzner D., et al. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall. Ann Rheum Dis 2005, 64(4):641-643.
74. Fauci A., Wolff S. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine 1973, 52:53-61.
75. Hoffman G.S., Kerr G.S., Leavitt R.Y., et al. Wegener's granulomatosis: an analysis of 158 Patients. Ann Intern Med 1992, 116:488-498.
76. Jayne D. Randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (CYCAZAREM). J Am Soc Nephrol 1999, 10:105A.
77. Pagnoux C., Mahr A., Hamidou M.A., et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008, 359(26):2790-2803.
78. Jayne D.R., Gaskin G., Rasmussen N., et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007, 18(7):2180-2188.
79. Silva F., Specks U., Kalra S., et al. Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement-a prospective, open-label pilot trial. Clin J Am Soc Nephrol 2010, 5(3):445-453.
80. De Groot K., Rasmussen N., Bacon P.A., et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005, 52(8):2461-2469.
81. Metzler C., Miehle N., Manger K., et al. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) 2007, 46(7):1087-1091.
82. Stone J.H., Merkel P.A., Seo P., et al. Rituximab versus cyclophosphamide for induction of remission in ANCA-Associated Vasculitis: a Randomized Controlled Trial (RAVE). Arthritis Rheum 2009, 60(Suppl):S204.
83. Calabrese L.H., Molloy E.S. Therapy: rituximab and PML risk-informed decisions needed!. Nat Rev Rheumatol 2009, 5(10):528-529.